MOST disabled women in Britain have been sexually harassed at work and some have left jobs to get away from it, the TUC’s first major report on the issue has found.
Some seven in 10 disabled women who took part in a survey reported suffering sexual harassment at work.
Younger disabled women, those aged 18 to 34, are even more likely to have experienced such harassment at work, with almost 80 per cent saying that they had.
Nearly 70 per cent of all who reported being sexually harassed said that they had not told their boss about the problem, with the most common reason being fear that they would not be taken seriously.
Lee Anderson MP speaks out after calling Stop Brexit Steve a parasite during confrontation
nottinghampost.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from nottinghampost.com Daily Mail and Mail on Sunday newspapers.
Janet Shapiro is at the National Pensioners Convention | Hampstead Highgate Express
hamhigh.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from hamhigh.co.uk Daily Mail and Mail on Sunday newspapers.
Follow RT on
Helen Buyniski is an American journalist and political commentator at RT. Follow her on Twitter @velocirapture23 and on Telegram The three largest producers of Covid-19 vaccines could have funded the entire cost of vaccinating Africa with the money they paid stockholders this year – and vaccine-sharing charity COVAX isn’t bridging the gap, analysis shows.
Pfizer, Johnson & Johnson, and AstraZeneca, the three top producers of Covid-19 vaccines, could fund the vaccination of the entire continent of Africa, some 1.3 billion people, vaccine advocacy group the People’s Vaccine Alliance revealed on Thursday.
Or rather, they
could have funded all those jabs if they hadn’t spent that money to pay out $26 billion in stock buybacks and dividends to their shareholders. The vaccines have largely been sold to wealthy countries, netting Pfizer/BioNTech and fellow mRNA vaccine producer Moderna a whopping $33.5 billion, and many of the recipient countries bought